Lung Cancer Diagnostic And Screening Growth Forecast 2025-2034: Trends, Opportunities, and Key Insights You Need to Know
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What is the Predicted CAGR for the Lung Cancer Diagnostic And Screening Market Over the Forecast Period of 2025 to 2034?
The lung cancer diagnostic and screening market has expanded considerably in recent years. It is forecasted to grow from $2.34 billion in 2024 to $2.56 billion in 2025 at a CAGR of 9.6%. This growth has been driven by advancements in digital imaging, standardization of screening protocols, public health initiatives against tobacco consumption, establishment of cancer registries, and innovations in pathology analysis.
The lung cancer diagnostic and screening market is expected to expand considerably, reaching $3.69 billion by 2029 at a CAGR of 9.5%. Factors fueling this growth include a rising incidence of lung cancer, heightened focus on early detection, the expansion of high-risk screening initiatives, a shift toward personalized medicine, and government-backed funding efforts. Notable trends include new screening technologies, improvements in biomarker testing, AI integration, increased use of liquid biopsy, and expanded low-dose CT screening programs.
What Are the Primary Drivers Supporting the Growth of the lung cancer diagnostic and screening Market?
The growing incidence of lung cancer is expected to propel the growth of the lung cancer diagnostic and screening market. Lung cancer, characterized by symptoms such as coughing and chest pain, requires early detection through methods like biopsies and bronchoscopies. In January 2023, the American Cancer Society reported 238,340 new cases and 127,070 deaths from lung cancer in the U.S. This increase in lung cancer cases will drive the demand for diagnostic and screening services.
Explore Comprehensive Insights Into The Global Lung Cancer Diagnostic And Screening Market With A Free Sample Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12043&type=smp
Who Are the Top Companies Driving Innovation and Growth in the Lung Cancer Diagnostic And Screening Market?
Major companies operating in the lung cancer diagnostic and screening market include:
• Pfizer Inc._x000D_
• F. Hoffmann-La Roche AG_x000D_
• Bristol-Myers Squibb Company_x000D_
• Thermo Fisher Scientific Inc._x000D_
• AstraZeneca Plc_x000D_
What Key Trends Are Currently Impacting the Lung Cancer Diagnostic And Screening Market’s Development?
In the lung cancer diagnostic and screening market, companies are developing technologies like lung cancer tests to improve early detection, diagnostic accuracy, and personalized treatment options for high-risk patients. For example, in December 2023, Freenome, a US-based biotechnology company, launched the PROACT LUNG trial. This innovative lung cancer screening test aims to revolutionize early detection and improve patient outcomes while addressing the shortcomings of current screening methods.
Secure Your Global Lung Cancer Diagnostic And Screening Market Report Now for Fast and Efficient Delivery!
What Are the Key Components of the Lung Cancer Diagnostic And Screening Market, and How Do Its Segments Perform?
The lung cancer diagnostic and screening market covered in this report is segmented –
1) By Product: Instruments, Consumables And Accessories
2) By Test: Biomarkers Tests, Imaging Test, Biopsy, Blood Test, Other Tests
3) By Cancer Type: Non-Small Cell Lung Cancer, Small Cell Lung Cancer
4) By End User: Hospital, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Users
Subsegments:
1) By Instruments: Imaging Devices, Biopsy Devices, Bronchoscopy Systems
2) By Consumables And Accessories: Biopsy Needles, Reagents And Assays, Imaging Contrast Agents, Patient Preparation Equipment, Sample Collection Kits, Laboratory Supplies
Which Geographical Regions Are Pioneering Growth in the Lung Cancer Diagnostic And Screening Market?
North America was the largest region in the lung cancer diagnostic and screening market in 2024. The regions covered in the lung cancer diagnostic and screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Do Experts Define the Scope of the Lung Cancer Diagnostic And Screening Market?
Lung cancer diagnosis and screening refers to using examinations and techniques to discover and identify lung cancer in people with the goal of early detection and precise diagnosis for efficient treatment planning. It is commonly used to treat squamous cell carcinomas, adenocarcinoma, and large cell carcinoma.
Browse Through More Similar Reports By The Business Research Company:
Hematology Drugs Global Market Report 2022
https://www.thebusinessresearchcompany.com/report/hematology-drug-global-market-report
Personal Services Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/personal-services-global-market-report
Toiletries Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/toiletries-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
